drugset / Trial / NCT00226642

Treatment of Mild and Subthreshold Depressive Disorders

NCT00226642 ↗

Phase 4 Unknown 369 enrolled Ludwig-Maximilians - University of Munich
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy of a SSRI, cognitive-bahavioral-therapy and a free choice between SSRI and CBT in a sample of primary care patients suffering from mild to moderate depression. Hypotheses: * SSRI is superior to placebo * CBT is superior to a non-specific supporting group therapy

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Met primary endpoint

paper Sertraline was superior to placebo (p = 0.03). PMID 19341510 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule — —

Indications